Search Results 101-110 of 832 for ❣[텔레문의:ABK0119] 햇살론유스 소액대출 급전대출 100만대출 당일대출❣

  1. A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...

  2. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer- ...

  3. Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia - Mayo Clinic

    About this study. This phase II trial studies how well sapanisertib works in treating patients with acute lymphoblastic leukemia that has returned after a ...

  4. Edwards Cardioband™ Tricuspid Valve Reconstruction System Early Feasibility Study - Mayo Clinic

    About this study. The purpose of this early feasibility study is to assess the safety and performance of the Edwards Cardioband™ FIT Valve Repair System.

  5. Neurology - Clinical trials - Mayo Clinic

    We anticipate identifying 100 patients with hemodynamic impairment as measured by an inter-hemispheral MRI perfusion "time to peak" (TTP) delay on the side of ...

  6. CC-4047 in Treating Patients With Myelofibrosis - Mayo Clinic

    About this study. RATIONALE: Biological therapies, such as CC-4047, may stimulate the immune system in different ways and stop cancer cells from growing.

  7. Drugs and Supplements that Start with S - Mayo Clinic

    Sinemet 100/25. Also known as. Carbidopa and levodopa (oral route). Sinemet 25 ... Soliqua 100/33. Also known as. Insulin glargine and lixisenatide ...

  8. A Study of AK002 in Patients with Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis - Mayo Clinic

    It is hypothesized that AK002 is more effective than placebo control (alternative hypothesis) in reducing the number of eosinophils per high power field (HPF) ...

  9. A Study to Evaluate Dapagliflozin to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure - Mayo Clinic

    The purpose of this international study is to evaluate the effect of dapagliflozin 10 mg versus placebo in HFpEF patients, given once daily in addition to ...

  10. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    This is a Phase III, multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of atezolizumab versus placebo in ...